If you have been reading about Visceral adipose tissue and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-05-14. Numbers and descriptions here follow the published literature rather than marketing material.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
| Property | Value | Notes |
|---|---|---|
| Drug class | Peptide hormone analog | Acts at the growth hormone-releasing hormone receptor |
| Receptor | Growth hormone-releasing hormone receptor | G protein-coupled; raises cyclic AMP in somatotrophs |
| Key mediator | Insulin-like growth factor 1 | Increases with repeated administration |
| Main studied population | Adults with HIV-associated lipodystrophy | Trials measured visceral adipose tissue by imaging |
| Route | Subcutaneous injection | Given once daily in clinical use |
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
== Facial arrangements == The amino acids that make up a particular helix can be plotted on a helical wheel, a representation that illustrates the orientations of the constituent amino acids (see the article for leucine zipper for such a diagram). Often in globular proteins, as well as in specialized structures such as coiled-coils and leucine zippers, an α-helix will exhibit two "faces" – one containing predominantly hydrophobic amino acids oriented toward the interior of the protein, in the hydrophobic core, and one containing predominantly polar amino acids oriented toward the solvent-exposed surface of the protein. Changes in binding orientation also occur for facially-organized oligopeptides. This pattern is especially common in antimicrobial peptides, and many models have been devised to describe how this relates to their function. Common to many of them is that the hydrophobic face of the antimicrobial peptide forms pores in the plasma membrane after associating with the fatty chains at the membrane core.
Food and biological process engineering is a discipline concerned with applying principles of engineering to the fields of food production and distribution and biology. It is a broad field, with workers fulfilling a variety of roles ranging from design of food processing equipment to genetic modification of organisms. In some respects it is a combined field, drawing from the disciplines of food science and biological engineering to improve the Earth's food supply. Creating, processing, and storing food to support the world's population requires extensive interdisciplinary knowledge. Notably, there are many biological engineering processes within food engineering to manipulate the multitude of organisms involved in our complex food chain. Food safety in particular requires biological study to understand the microorganisms involved and how they affect humans. However, other aspects of food engineering, such as food storage and processing, also require extensive biological knowledge of both the food and the microorganisms that inhabit it. This food microbiology and biology knowledge becomes biological engineering when systems and processes are created to maintain desirable food properties and microorganisms while providing mechanisms for eliminating the unfavorable or dangerous ones.
Glycerol is used in medical, pharmaceutical and personal care preparations, often as a means of improving smoothness, providing lubrication, and as a humectant. Ichthyosis and xerosis have been relieved by the topical use of glycerin. It is found in allergen immunotherapies, cough syrups, elixirs, expectorants, toothpastes, mouthwashes, skin care products, shaving cream, hair care products, soaps, and water-based personal lubricants. It is used to keep tablets and other solid dosage forms from falling apart. For human consumption, glycerol is classified by the FDA among the sugar alcohols as a caloric macronutrient. Glycerol is also used in blood banking to preserve red blood cells prior to freezing. Taken rectally, glycerol functions as a laxative by irritating the anal mucosa and inducing a hyperosmotic effect, expanding the colon by drawing water into it to induce peristalsis resulting in evacuation. It may be administered undiluted as a suppository, or as a small-volume (2–10 ml) enema. Alternatively, it may be administered in a dilute solution, such as 5%, as a high-volume enema. Taken orally (often mixed with fruit juice to reduce its sweet taste), glycerol can cause a rapid, temporary decrease in the internal pressure of the eye. This can be useful for the initial emergency treatment of severely elevated eye pressure. In 2017, researchers showed that the probiotic Limosilactobacillus reuteri bacteria can be supplemented with glycerol to enhance its production of antimicrobial substances in the human gut.
Valerylfentanyl is an opioid analgesic that is an analog of fentanyl and has been sold online as a designer drug. It has been seldom reported on illicit markets and there is little information about it, though it is believed to be less potent than butyrfentanyl but more potent than benzylfentanyl. In one study, it fully substituted for oxycodone and produced antinociception and oxycodone-like discriminative stimulus effects comparable in potency to morphine in mice, but failed to stimulate locomotor activity in mice at doses up to 100 mg/kg.
Sources: en.wikipedia.org
== Health and safety == Certain blue LEDs and cool-white LEDs can exceed safe limits of the so-called blue-light hazard as defined in eye safety specifications such as "ANSI/IESNA RP-27.1–05: Recommended Practice for Photobiological Safety for Lamp and Lamp Systems". One study showed no evidence of a risk in normal use at domestic illuminance, and that caution is only needed for particular occupational situations or for specific populations. In 2006, the International Electrotechnical Commission published IEC 62471 Photobiological safety of lamps and lamp systems, replacing the application of early laser-oriented standards for classification of LED sources. While LEDs have the advantage over fluorescent lamps, in that they do not contain mercury, they may contain other hazardous metals such as lead and arsenic. In 2016 the American Medical Association (AMA) issued a statement concerning the possible adverse influence of blueish street lighting on the sleep-wake cycle of city-dwellers. Critics in the industry claim exposure levels are not high enough to have a noticeable effect.
According to limerence theory, posited in 1979 by psychologist Dorothy Tennov, a certain percentage of couples may go through what is called a limerent reaction, in which one or both of the pair may experience a state of passion mixed with continuous intrusive thinking, fear of rejection, and hope. Hence, with all human romantic relationships, one of three varieties of bonds may form, defined over a set duration of time, in relation to the experience or non-experience of limerence:
=== Early work === Following the completion of his formal education, Stein became a researcher under Bergmann at Rockefeller Institute, where much of his most important work was done. Stanford Moore joined Bergmann's lab in 1939, where he and Stein began research focusing on amino acids. According to Moore, "During the early years of our cooperation, Stein and I worked out a system of collaboration that lasted for a lifetime." Their work in this area was disrupted with the beginning of World War II, and they temporarily parted ways to aid the war efforts, Stein staying with Bergmann to research the molecular scale effect of blister agents on the human body. They began collaborating again, however, after Bergmann died in 1944 and they were given an opportunity by the Director of the Rockefeller Institute, Herbert S. Gasser, to continue Bergmann's work in amino acids.
According to Richards, Campania, & Muse-Burke, "There is growing evidence that is showing emotional abilities are associated with pro-social behaviors such as stress management and physical health." Their research also concluded that people who lack emotional expression are inclined to anti-social behaviors (e.g., substance use disorder and alcohol use disorder, physical fights, vandalism), which reflects one's mental health and suppressed emotions. Adults and children who face mental illness may experience social stigma, which can exacerbate the issues.
=== Risk to humans === The odorous secretions produced by American cockroaches can alter the flavor of food. Also, if populations of cockroaches are high, a strong concentration of this odorous secretion can be present. Cockroaches can pick up disease-causing bacteria, such as Salmonella, on their legs, and later deposit them on foods and cause food poisoning or infection if they walk on the food. House dust containing cockroach feces and body parts can trigger allergic reactions and asthma in certain individuals. At least 22 species of pathogenic human bacteria, viruses, fungi, and protozoans, as well as five species of helminthic worms, have been isolated from field-collected P. americana (L.)
Sources: en.wikipedia.org
== See also == China–United States trade war Kondratiev wave CHIPS and Science Act European Chips Act Global Partnership on Artificial Intelligence Partnership on AI Pax Silica World Artificial Intelligence Cooperation Organization AI nationalism AI tiger
=== Odor problem === DMSO disposed into sewers can cause odor problems in municipal effluents: waste water bacteria transform DMSO under hypoxic (anoxic) conditions into dimethyl sulfide (DMS) that has a strong disagreeable odor, similar to rotten cabbage. However, chemically pure DMSO is odorless because of the lack of C-S-C (sulfide) and C-S-H (mercaptan) linkages. Deodorization of DMSO is achieved by removing the odorous impurities it contains.
==== MeSH D13.695.667 – purine nucleotides ==== MeSH D13.695.667.138 – adenine nucleotides MeSH D13.695.667.138.124 – adenosine diphosphate MeSH D13.695.667.138.124.070 – adenosine diphosphate sugars MeSH D13.695.667.138.124.070.075 – adenosine diphosphate glucose MeSH D13.695.667.138.124.070.125 – adenosine diphosphate ribose MeSH D13.695.667.138.124.070.125.040 – o-acetyl-adp-ribose MeSH D13.695.667.138.124.070.125.195 – cyclic adp-ribose MeSH D13.695.667.138.180 – adenosine monophosphate MeSH D13.695.667.138.180.080 – adenosine phosphosulfate MeSH D13.695.667.138.236 – adenosine triphosphate MeSH D13.695.667.138.236.050 – adenylyl imidodiphosphate MeSH D13.695.667.138.236.250 – ethenoadenosine triphosphate MeSH D13.695.667.138.382 – coenzyme a MeSH D13.695.667.138.382.300 – acyl coenzyme a MeSH D13.695.667.138.382.300.020 – acetyl coenzyme a MeSH D13.695.667.138.382.300.500 – malonyl coenzyme a MeSH D13.695.667.138.382.300.700 – palmitoyl coenzyme a MeSH D13.695.667.138.395 – cyclic amp MeSH D13.695.667.138.395.225 – 8-bromo cyclic adenosine monophosphate MeSH D13.695.667.138.395.250 – bucladesine MeSH D13.695.667.138.410 – deoxyadenine nucleotides MeSH D13.695.667.138.506 – flavin-adenine dinucleotide MeSH D13.695.667.138.694 – nad MeSH D13.695.667.138.749 – nadp MeSH D13.695.667.138.850 – phosphoadenosine phosphosulfate MeSH D13.695.667.138.925 – vidarabine phosphate MeSH D13.695.667.454 – guanine nucleotides MeSH D13.695.667.454.160 – cyclic gmp MeSH D13.695.667.454.160.325 – dibutyryl cyclic gmp MeSH D13.695.667.454.200 – deoxyguanine nucleotides MeSH D13.695.667.454.340 – guanosine diphosphate MeSH D13.695.667.454.340.350 – guanosine diphosphate sugars MeSH D13.695.667.454.340.350.400 – guanosine diphosphate fucose MeSH D13.695.667.454.340.350.500 – guanosine diphosphate mannose MeSH D13.695.667.454.440 – guanosine pentaphosphate MeSH D13.695.667.454.480 – guanosine tetraphosphate MeSH D13.695.667.454.504 – guanosine triphosphate MeSH D13.695.667.454.504.380 – guanosine 5'-o-(3-thiotriphosphate) MeSH D13.695.667.454.504.400 – guanylyl imidodiphosphate MeSH D13.695.667.454.525 – 5'-guanylic acid MeSH D13.695.667.454.700 – rna caps MeSH D13.695.667.454.700.710 – rna cap analogs MeSH D13.695.667.616 – inosine nucleotides MeSH D13.695.667.616.300 – cyclic imp MeSH D13.695.667.616.400 – inosine diphosphate MeSH D13.695.667.616.500 – inosine monophosphate MeSH D13.695.667.616.800 – inosine triphosphate
The LSI is a 235,000 square feet building with six floors, located between U-M's central campus and the university's medical campus in Ann Arbor. Completed in 2003, the building includes housing for wet lab and laboratory support spaces, administration offices, PI offices, interaction spaces, core laboratory areas, a combined gallery/lobby space and a small library. The exterior design of the building is intended to harmonize with other campus loft-style structures, while also meeting the needs of a modern research institute.
To get more control on the regiospecific polymer synthesis, copolymerization was proposed. One of these methods is introducing the precursor polymer made from copolymerization of VF2 with either 1-chloro-2,2-difluoroethylene (CVF2) or 1-bromo-2,2-difluoroethylene (BVF2). The chlorinated or brominated monomers are attacked at their CF2 carbon by growing –CH2CF2∙ radical. After reductive dechlorination or debromination with tri-n-butyltin hydride they become a reversed VF2 unit in the final polymer. Therefore, a regioisomer of PVDF is formed.
Sources: en.wikipedia.org
It is a laboratory-made peptide that mimics growth hormone-releasing hormone. It prompts the pituitary gland to release growth hormone and has been studied mainly in adults with HIV-associated lipodystrophy.
Administered growth hormone supplies the hormone directly, while this peptide acts upstream by prompting the pituitary to release it. The indirect route preserves pulsatile secretion and some endogenous feedback, which changes the hormone and IGF-1 profile observed after treatment.
Reductions in visceral adipose tissue appear consistently in randomized trials of the approved population. Effects on peripheral fat, cardiovascular outcomes, and use outside that population are less well established.
No. It is a peptide that acts upstream of growth hormone release, while growth hormone is the hormone itself. The two differ in size, in receptor, and in how the body clears them.